Scholarlink

Background <p>Neoadjuvant therapy is recommended for hepatocellular carcinoma at advanced stages. It is unknown whether robotic liver resection (RLR) is superior to open liver resection (OLR) after neoadjuvant therapy.</p> Methods <p>We analyzed consecutive RLR and OLR patients from December 2020 to December 2023. Patient variables, short- and long-term outcomes were compared. A respective 1:3 propensity score-matched (PSM) analysis was performed between RLR and OLR groups.</p> Results <p>The analysis included 32 RLR and 386 OLR cases. After PSM, 29 RLR cases matched to 78 OLR cases. RLR had similar operative time, fewer blood loss (123&#xa0;mL vs. 230&#xa0;mL, <i>P</i> = 0.032), and shorter postoperative hospital stay (7.2&#xa0;days vs. 10.4&#xa0;days, <i>P</i> = 0.014) compared to OLR. RLR had similar incidence and grades of complications compared to OLR. No significant difference was found in recurrence-free and overall survival.</p> Conclusion <p>RLR after neoadjuvant therapy was as safe and feasible as OLR, and could improve postoperative recovery and produce equivalent long-term survival outcomes.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Robotic vs. open liver resection after neoadjuvant therapy for hepatocellular carcinoma: a propensity score-matched analysis of short- and long-term outcomes

  • 期刊论文

  • 发表日期：

    2026年4月20日

查看全文
  • Xiaoyu Zhang,
  • Rui Li,
  • Wei Chen,
  • Yufu Ye,
  • Yifan Hong,
  • Yiwen Chen,
  • Xiang Li,
  • Wendi Hu,
  • Zhenglong Zhai,
  • Jiaqi Yang,
  • Yan Shen,
  • Min Zhang,
  • Jian Wu,
  • Shunliang Gao,
  • Jun Yu,
  • Risheng Que,
  • Xueli Bai,
  • Tingbo Liang

摘要

Background

Neoadjuvant therapy is recommended for hepatocellular carcinoma at advanced stages. It is unknown whether robotic liver resection (RLR) is superior to open liver resection (OLR) after neoadjuvant therapy.

Methods

We analyzed consecutive RLR and OLR patients from December 2020 to December 2023. Patient variables, short- and long-term outcomes were compared. A respective 1:3 propensity score-matched (PSM) analysis was performed between RLR and OLR groups.

Results

The analysis included 32 RLR and 386 OLR cases. After PSM, 29 RLR cases matched to 78 OLR cases. RLR had similar operative time, fewer blood loss (123 mL vs. 230 mL, P = 0.032), and shorter postoperative hospital stay (7.2 days vs. 10.4 days, P = 0.014) compared to OLR. RLR had similar incidence and grades of complications compared to OLR. No significant difference was found in recurrence-free and overall survival.

Conclusion

RLR after neoadjuvant therapy was as safe and feasible as OLR, and could improve postoperative recovery and produce equivalent long-term survival outcomes.

Graphical abstract